Human Papillomavirus Early Proteins (E1, E2, E4, E5, E6, E7) (HPV Early Proteins (E1-E7))

The human papillomavirus (HPV) early proteins (E1, E2, E4, E5, E6, and E7) are a group of regulatory proteins essential for the HPV lifecycle. They play crucial roles in viral replication, transcription, cell cycle manipulation, and immune evasion. Specifically, E1 is a helicase that initiates viral DNA replication. E2 regulates viral gene transcription. E4 modulates cell cycle progression and disrupts the cytoskeleton. E5 alters cell signaling pathways. E6 and E7 are oncoproteins that promote cellular transformation by targeting key tumor suppressor proteins like p53 and pRb, respectively. Persistent expression of E6 and E7 is critical for HPV-driven carcinogenesis, making them attractive therapeutic targets.

Other names

HPV E1 proteinHPV E2 proteinHPV E4 proteinHPV E5 proteinHPV E6 proteinHPV E7 protein

Various, depending on the specific protein and drug. E1 inhibitors would block viral replication. E2 modulators would affect viral transcription. E6/E7 inhibitors would disrupt their oncogenic activity (e.g., by restoring p53 or pRb function).